Scarica l'app Stockscreener
0.4101
0.84%
0.0034
Pre-mercato:
.42
0.0099
+2.41%
Precedente Chiudi:
$0.4067
Aprire:
$0.41
Volume 24 ore:
463.50K
Relative Volume:
0.06
Capitalizzazione di mercato:
$60.13M
Reddito:
$49.09M
Utile/perdita netta:
$-52.15M
Rapporto P/E:
-0.6309
EPS:
-0.65
Flusso di cassa netto:
$-45.93M
1 W Prestazione:
+6.94%
1M Prestazione:
+28.44%
6M Prestazione:
-55.47%
1 anno Prestazione:
-76.43%
Intervallo 1D:
$0.3844
$0.4143
Intervallo di 1 settimana:
$0.372
$0.43
Portata 52W:
$0.1718
$2.04
Biodesix Inc Stock (BDSX) Company Profile
Nome
Biodesix Inc
Settore
Industria
Telefono
303-417-0500
Indirizzo
919 WEST DILLON ROAD, LOUISVILLE
Confronta BDSX con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
BDSX
Biodesix Inc
|
0.4101 | 62.32M | 49.09M | -52.15M | -45.93M | -0.65 |
|
TMO
Thermo Fisher Scientific Inc
|
494.81 | 184.10B | 43.21B | 6.58B | 6.17B | 17.29 |
|
DHR
Danaher Corp
|
211.40 | 149.66B | 24.01B | 3.41B | 4.86B | 4.70 |
|
IDXX
Idexx Laboratories Inc
|
639.85 | 51.03B | 4.04B | 985.66M | 774.34M | 12.01 |
|
A
Agilent Technologies Inc
|
119.11 | 33.56B | 6.63B | 1.17B | 1.19B | 4.05 |
|
IQV
Iqvia Holdings Inc
|
192.04 | 32.73B | 15.70B | 1.24B | 2.01B | 6.91 |
Biodesix Inc Stock (BDSX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-05-14 | Downgrade | William Blair | Outperform → Mkt Perform |
| 2024-09-16 | Iniziato | Scotiabank | Sector Outperform |
| 2024-07-26 | Iniziato | Craig Hallum | Buy |
| 2024-05-13 | Iniziato | TD Cowen | Buy |
| 2024-05-03 | Iniziato | Lake Street | Buy |
| 2021-11-17 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2020-11-23 | Iniziato | BTIG Research | Buy |
| 2020-11-23 | Iniziato | Canaccord Genuity | Buy |
| 2020-11-23 | Iniziato | Morgan Stanley | Overweight |
| 2020-11-23 | Iniziato | William Blair | Outperform |
Mostra tutto
Biodesix Inc Borsa (BDSX) Ultime notizie
Fibonacci Support Holding Strong in Biodesix Inc.July 2025 Institutional & Weekly Sector Rotation Insights - classian.co.kr
Will Biodesix Inc. Reverse From Oversold ConditionsQuarterly Performance Summary & AI Based Buy and Sell Signals - beatles.ru
Biodesix Recognized as a Thermo Fisher Scientific Center of Excellence (COE) for NGS Diagnostics - GlobeNewswire
Biodesix Designated Thermo Fisher Center of Excellence for NGS-Based Diagnostics. - AInvest
Biodesix Validates Thermo Fisher's Oncomine Dx Express Test for Solid Tumors on Genexus Dx Integrated Sequencer. - AInvest
Major Diagnostic Partnership: Biodesix Joins Elite Group as Thermo Fisher Center of Excellence for Cancer Testing - Stock Titan
Wyckoff Accumulation Phase Possible in Biodesix Inc.July 2025 Review & Long-Term Growth Stock Strategies - newsimpact.co.kr
Options Data Show Bullish Bias in Biodesix Inc.July 2025 Breakouts & AI Enhanced Market Trend Forecasts - newsyoung.net
Biodesix, Inc. Reports Strong Q2 2025 Growth - MSN
What makes Biodesix Inc. stock price move sharplyBond Market & Short-Term Trading Alerts - thegnnews.com
Biodesix Inc. Stocks Attracting Dip BuyersJuly 2025 Macro Moves & AI Enhanced Market Trend Forecasts - newsyoung.net
Is This the Dip to Buy in Biodesix Inc.Wall Street Watch & AI Driven Price Predictions - newsimpact.co.kr
What MACD and RSI say about Biodesix Inc.Portfolio Risk Summary & Weekly Breakout Watchlists - Newser
Biodesix (NASDAQ:BDSX) Releases Earnings Results - MarketBeat
Combining machine learning predictions for Biodesix Inc.2025 Technical Patterns & Risk Managed Investment Signals - Newser
Price momentum metrics for Biodesix Inc. explainedJuly 2025 Decliners & Smart Money Movement Alerts - Newser
Combining price and volume data for Biodesix Inc.Quarterly Profit Review & Community Verified Watchlist Alerts - Newser
AI Indicators Detect Buy Opportunity in Biodesix Inc.CEO Change & Fast Entry and Exit Trade Plans - kangso.co.kr
Can Biodesix Inc. Outperform Peers After Recent PullbackExit Point & Proven Capital Preservation Methods - thegnnews.com
Will Biodesix Inc. Benefit From Sector TailwindsTrade Performance Summary & Low Volatility Stock Recommendations - newsimpact.co.kr
Blair William & Co. IL Has $78,000 Stake in Biodesix, Inc. (NASDAQ:BDSX) - Defense World
Is a relief rally coming for Biodesix Inc. holders2025 Performance Recap & AI Powered Buy and Sell Recommendations - Newser
Will Biodesix Inc. bounce back from current supportFed Meeting & Risk Managed Investment Strategies - Newser
Earnings visualization tools for Biodesix Inc.2025 Market Sentiment & Free AI Powered Buy and Sell Recommendations - Newser
Biodesix at Canaccord Conference: Strategic Expansion in Diagnostics By Investing.com - Investing.com Canada
Is Biodesix Inc. a strong growth stockUndervalued High Return Candidates - kangso.co.kr
Investors Still Aren't Entirely Convinced By Biodesix, Inc.'s (NASDAQ:BDSX) Revenues Despite 26% Price Jump - 富途牛牛
Biodesix, Inc. (NASDAQ:BDSX) Q2 2025 Earnings Call Transcript - Insider Monkey
Biodesix, Inc. (NASDAQ:BDSX) Just Reported Earnings, And Analysts Cut Their Target Price - 富途牛牛
Should I add Biodesix Inc. stock to my portfolioMulti-Year Breakout Candidates - thegnnews.com
Earnings Release: Here's Why Analysts Cut Their Biodesix, Inc. (NASDAQ:BDSX) Price Target To US$1.80 - Yahoo Finance
Biodesix 2025 Q2 Earnings Revenue Grows 11.7% Amid Expanding Losses - AInvest
Biodesix reports strong Q2 revenue growth - BizWest
Biodesix, Inc. (BDSX) Reports Q2 Loss, Tops Revenue Estimates - MSN
Biodesix, Inc. shares fall 9.84% intraday despite Q2 revenue beating estimates. - AInvest
Transcript : Biodesix, Inc., Q2 2025 Earnings Call, Aug 07, 2025 - MarketScreener
Biodesix Plunges 11.63% on Q2 Loss, Revenue Surprise - AInvest
Biodesix Reports Strong Q2 2025 Revenue Growth - TipRanks
Biodesix Maintains Hold Rating Amid Revenue Growth and Cash Flow Challenges - AInvest
Biodesix Inc (BDSX) Q2 2025 Earnings Call Highlights: Revenue Growth and Strategic Expansion ... By GuruFocus - Investing.com Canada
Biodesix Inc (BDSX) Q2 2025 Earnings Call Highlights: Revenue Gr - GuruFocus
Biodesix Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Biodesix Outpaces Expectations With Lung Test Growth And Upbeat Outlook - Finimize
Diagnostic firm Biodesix Q2 revenue beats estimates - MarketScreener
Biodesix earnings missed, revenue topped estimates By Investing.com - Investing.com South Africa
Biodesix earnings missed, revenue topped estimates - Investing.com
Biodesix Announces Second Quarter 2025 Results and Highlights - The Manila Times
Biodesix Soars 14.1% on Conference Presentation - AInvest
Biodesix Stock Soars 12.82% on Strong Q1 Earnings - AInvest
Biodesix Inc Azioni (BDSX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Biodesix Inc Azioni (BDSX) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Hutton Scott | President & CEO |
Aug 13 '25 |
Sale |
0.42 |
3,772 |
1,570 |
728,824 |
| O'Kane Kieran | Chief Commercial Officer |
Aug 13 '25 |
Sale |
0.42 |
476 |
198 |
140,065 |
| Pestano Gary Anthony | Chief Development Officer |
Aug 13 '25 |
Sale |
0.42 |
442 |
184 |
157,878 |
| Vazquez Chris | Chief Accounting Officer |
Aug 13 '25 |
Sale |
0.42 |
228 |
95 |
18,375 |
| SCHULER JACK W | Director |
May 16 '25 |
Buy |
0.27 |
4,000,000 |
1,070,000 |
20,194,935 |
| SCHULER JACK W | Director |
May 19 '25 |
Buy |
0.34 |
723,239 |
246,624 |
20,918,174 |
| Vazquez Chris | Chief Accounting Officer |
May 12 '25 |
Sale |
0.36 |
112 |
40 |
18,113 |
| Vazquez Chris | Chief Accounting Officer |
May 13 '25 |
Sale |
0.35 |
112 |
40 |
18,001 |
| Pestano Gary Anthony | Chief Development Officer |
May 12 '25 |
Sale |
0.36 |
223 |
80 |
157,163 |
| Pestano Gary Anthony | Chief Development Officer |
May 13 '25 |
Sale |
0.35 |
222 |
78 |
156,941 |
0.33%
0.86%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):